Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p>In prenatal care, accumulating evidences has demonstrated that whole‐exome sequencing (WES) expedites the genetic diagnosis of fetal structural anomalies. However, the clinical value of WES in the diagnosis of prenatal isolated congenital anomalies of the kidney and urinary tract (CAKUT) is unknown.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>Forty‐one fetuses with unexplained isolated CAKUT, normal karyotype and negative chromosomal microarray analysis (CMA) results, underwent WES and were accordingly grouped as (a) Group 1: complex cases with bilateral renal abnormalities (N = 19); and (b) Group 2: cases with isolated unilateral fetal renal abnormalities (N = 22).</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>The detection rate of WES for pathogenic variants and incidental variants was 7.32% (3/41) and 2.4% (1/41), respectively. The three pathogenic variants were identified in the genes <i>ACTA2 </i> (multisystem smooth muscle dysfunction syndrome), <i>PKHD1 </i> (autosomal recessive form of polycystic kidney disease), and <i>PKD1 </i> (autosomal dominant polycystic kidney disease type 1). The incidental variants were detected in genes <i>PPM1D </i> (syndromic neurodevelopmental disorders). Furthermore, all above fetuses carrying pathogenic variants came from bilateral kidney anomalies. Thus, the detection rate was 0 for fetuses with unilateral fetal renal <i>abnormalities </i> and 15.7% (3/19) for bilateral renal abnormalities. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusion</h3><p>This cohort shows that prenatal WES is a supplementary approach for the etiologic diagnosis of unexplained isolated CAKUT with negative CMA, especially for fetuses with bilateral renal abnormality.</p></section>

Ultra-rare renal diseases diagnosed with whole-exome sequencing: Utility in diagnosis and management

Diagnostic and Clinical Utility of Whole Genome Sequencing in a Cohort of Undiagnosed Chinese Families with Rare Diseases

Identification of extremely rare mitochondrial disorders by whole exome sequencing

The application of whole-exome sequencing in the early diagnosis of rare genetic diseases in children: a study from Southeastern China

Molecular diagnostic in fetuses with isolated congenital anomalies of the kidney and urinary tract by whole‐exome sequencing

Diagnostic Yield and Benefits of Whole Exome Sequencing in CAKUT Patients Diagnosed in the First Thousand Days of Life

Clinical use of whole exome sequencing in children with developmental delay/intellectual disability

New insights from trio whole-exome sequencing in the children with kidney disease: A single-center retrospective cohort study

Diagnostic application of exome sequencing in Chinese children with suspected inherited kidney diseases

Panel Sequencing Distinguishes Monogenic Forms of Nephritis from Nephrosis in Children

Exome and genome sequencing in a heterogeneous population of patients with rare disease: Identifying predictors of a diagnosis

Whole-exome analysis of 177 pediatric patients with undiagnosed diseases

[Application of whole exome sequencing technology in the diagnosis of hereditary eye diseases]

The usefulness of whole-exome sequencing in routine clinical practice

Prenatal diagnosis of fetuses with ultrasound anomalies by whole-exome sequencing in Luoyang city, China

Clinical Application of Whole Exome Sequencing for Monogenic Disorders in PICU of China

Whole exome sequencing as a diagnostic adjunct to clinical testing in fetuses with structural abnormalities

Clinical application of whole-exome sequencing across clinical indications

Whole exome sequencing approach for identification of the molecular etiology in pediatric patients with hematuria

Is Whole Exome Sequencing Clinically Practical in the Management of Pediatric Crohn's Disease?

Advocating Targeted Sequential Screening over Whole Exome Sequencing in 21-Hydroxylase Deficiency